Schteingart, David E; Sinsheimer, Joseph E; Benitez, Ricardo S et al. (2012) Structural requirements for mitotane activity: development of analogs for treatment of adrenal cancer. Anticancer Res 32:2711-20
|
Cai, W; Counsell, R E; Schteingart, D E et al. (1997) Adrenal proteins bound by a reactive intermediate of mitotane. Cancer Chemother Pharmacol 39:537-40
|
Sinsheimer, J E; Counsell, R E; Cai, W et al. (1996) Gas chromatographic-electron capture determination of 2,4'-dichlorodiphenylacetic acid from in-vitro adrenal transformations of mitotane and its analogs. J Pharm Biomed Anal 14:861-6
|
Cai, W; Counsell, R E; Djanegara, T et al. (1995) Metabolic activation and binding of mitotane in adrenal cortex homogenates. J Pharm Sci 84:134-8
|
Cai, W; Benitez, R; Counsell, R E et al. (1995) Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane;o,p'-DDD] and its p,p'- and m,p'-isomers. Biochem Pharmacol 49:1483-9
|
Schteingart, D E; Sinsheimer, J E; Counsell, R E et al. (1993) Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma. Cancer Chemother Pharmacol 31:459-66
|
Sinsheimer, J E; Freeman, C J (1987) Mitotane (1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane) metabolism in perfusion studies with dog adrenal glands. Drug Metab Dispos 15:267-9
|
Musial, S P; Freeman, C J; Sinsheimer, J E (1985) Mitotane (o,p'-DDD) emulsion and tablet analysis by high-performance liquid chromatography. J Chromatogr 319:467-70
|